RT Journal Article SR Electronic T1 Temporal trends in primary care-recorded self-harm during and beyond the first year of the COVID-19 pandemic: time series analysis of electronic healthcare records for 2.8 million patients in the Greater Manchester Care Record JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.06.23.21259400 DO 10.1101/2021.06.23.21259400 A1 Sarah Steeg A1 Lana Bojanić A1 George Tilston A1 Richard Williams A1 David A. Jenkins A1 Matthew J. Carr A1 Niels Peek A1 Darren M. Ashcroft A1 Nav Kapur A1 Jennifer Voorhees A1 Roger T. Webb YR 2021 UL http://medrxiv.org/content/early/2021/06/30/2021.06.23.21259400.abstract AB Background Surveillance of clinically treated self-harm episode frequency is an important component of suicide prevention in the dynamic context of COVID-19. Studies published to date have investigated the initial months following the onset of the pandemic, despite national and regional restrictions persisting to Summer 2021.Methods We conducted a descriptive time series analysis utilising data from the Greater Manchester Care Record, which contains de-identified, primary care health records of 2.8 million patients. Counts of incident and all episodes of self-harm recorded between 1st January 2019 and 31st May 2021 were made for all patients, with stratification by sex, age group, ethnicity, and index of multiple deprivation (IMD) quintile and examination of overall differences by national and regional restriction phases.Findings Between 1st January 2019 and 31st May 2021, 33,444 episodes of self-harm by 13,148 individuals were recorded. Frequency ratios of incident and all episodes of self-harm were 0.59 (95% CI 0.51 to 0.69) and 0.69 (CI 0.63 to 0.75) respectively in April 2020 compared to February 2020. Between August 2020 and May 2021 frequency ratios were 0.92 (CI 0.88 to 0.96) for incident episodes and 0.86 (CI 0.84 to 0.88) for all episodes compared to the same months in 2019. Reductions were largest among men and people living in the most deprived neighbourhoods. An increase in all-episode self-harm (frequency ratio 1.09, CI 1.03 to 1.16) was observed for adolescents aged 10-17 between August 2020 and May 2021.Interpretation The COVID-19 pandemic has had a sustained impact on help seeking for self-harm. Reductions in primary care recorded self-harm have implications for clinicians’ ability to assess the needs and risks of individuals. Some patients may be experiencing prolonged untreated deterioration in their mental health while other groups are presenting in higher numbers. Our findings have important implications for primary care and mental health services in manging ongoing demand.Funding UKRI COVID-19 Rapid Response Initiative (grant reference COV0499), University of Manchester Presidential Fellowship (SS), and NIHR Greater Manchester Patient Safety Translational Research Centre.Competing Interest StatementNK reports grants and personal fees from the UK Department of Health and Social Care, the National Institute of Health Research (NIHR), the National Institute for Health and Care Excellence (NICE), and the Healthcare Quality and Improvement Partnership, outside the submitted work; works with NHS England on national quality improvement initiatives for suicide and self-harm; is a member of the advisory group for the National Suicide Prevention Strategy of the Department of Health and Social Care; has chaired NICE guideline committees for Self-harm and Depression; and is currently the Topic Advisor for the new NICE Guidelines for self-harm. All other authors report no conflicts of interest.Funding StatementThis work was funded by the UK Research and Innovation/Medical Research Council COVID-19 Rapid Response Initiative (grant reference COV0499) (RTW & SS, NK, DMA, MJC) and by a University of Manchester Presidential Fellowship (SS). MJC, DMA, NK, NP, RW, DAJ and RTW are funded by the National Institute for Health Research (NIHR) Greater Manchester Patient Safety Translational Research Centre. GT and NP are funded by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Greater Manchester Care Record Research Governance Group approved the protocol (reference RQ-029) for this study in March 2021. All patient data were de-identified and informed consent was therefore not needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe clinical codes used in this study are available online at https://github.com/rw251/gm-idcr/tree/master/shared/clinical-code-sets/patient/selfharm-episodes/1. The codes are also available from the corresponding author on request. Access to data are only available upon approval by the GMCR Research Governance Group. https://github.com/rw251/gm-idcr/tree/master/shared/clinical-code-sets/patient/selfharm-episodes/1